A Study of the Effects of RoActemra/Actemra on Vaccination in Patients With Rheumatoid Arthritis on Background Methotrexate (VISARA)
Public ClinicalTrials.gov record NCT01163747. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Randomized, Parallel-group, Open-label, Multicenter Study to Evaluate the Effects of Tocilizumab on Vaccination in Subjects With Active Rheumatoid Arthritis Receiving Background Methotrexate
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This randomized, parallel-group, open-label study will evaluate the effect of Actemra (tocilizumab) on vaccination in patients with active rheumatoid arthritis who have an inadequate response to methotrexate and who have had an inadequate clinical response or were intolerant to treatment with one or more anti-tumor necrosis factor (anti-TNF) therapies.
Study identification
- NCT ID
- NCT01163747
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 91 participants
Conditions and interventions
Conditions
Interventions
- tocilizumab Biological
- methotrexate Drug
- 23-Valent Pneumococcal Polysaccharide Vaccine Biological
- Tetanus Toxoid Adsorbed Vaccine Biological
Biological · Drug
Eligibility (public fields only)
- Age range
- 18 Years to 64 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Sep 2010 (Type not available)
- Primary completion
- Dec 2011 (Actual)
- Completion
- Jun 2012 (Actual)
- Last update posted
- Dec 7, 2012
2010 – 2012
United States locations
- U.S. sites
- 47
- U.S. states
- 23
- U.S. cities
- 45
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Not listed | Anniston | Alabama | 36207 | — |
| Not listed | Birmingham | Alabama | 35294 | — |
| Not listed | Huntsville | Alabama | 35801 | — |
| Not listed | Glendale | Arizona | 85304 | — |
| Not listed | Mesa | Arizona | 85202 | — |
| Not listed | Paradise Valley | Arizona | 85037 | — |
| Not listed | Paradise Valley | Arizona | 85253 | — |
| Not listed | Scottsdale | Arizona | 85258 | — |
| Not listed | Jonesboro | Arkansas | 72401 | — |
| Not listed | Fullerton | California | 92835 | — |
| Not listed | Hemet | California | 92543 | — |
| Not listed | San Leandro | California | 94578 | — |
| Not listed | Santa Maria | California | 93454 | — |
| Not listed | Upland | California | 91786 | — |
| Not listed | Bridgeport | Connecticut | 06606 | — |
| Not listed | Melbourne | Florida | 32901 | — |
| Not listed | South Miami | Florida | 33143 | — |
| Not listed | Tavares | Florida | 32778 | — |
| Not listed | Boise | Idaho | 83702 | — |
| Not listed | Idaho Falls | Idaho | 83404 | — |
| Not listed | Maywood | Illinois | 60153 | — |
| Not listed | Vernon Hills | Illinois | 60061 | — |
| Not listed | South Bend | Indiana | 46601 | — |
| Not listed | Baltimore | Maryland | 21224 | — |
| Not listed | Baltimore | Maryland | 21286 | — |
| Not listed | Saint Clair Shores | Michigan | 48080 | — |
| Not listed | Tupelo | Mississippi | 38801 | — |
| Not listed | Las Vegas | Nevada | 89128 | — |
| Not listed | Manalapan | New Jersey | 07726 | — |
| Not listed | Albany | New York | 12206 | — |
| Not listed | Belmont | North Carolina | 28012 | — |
| Not listed | Charlotte | North Carolina | 28210 | — |
| Not listed | Greenville | North Carolina | 27834 | — |
| Not listed | Cleveland | Ohio | 44109 | — |
| Not listed | Gallipolis | Ohio | 45631 | — |
| Not listed | Middleburg Heights | Ohio | 44130 | — |
| Not listed | Lake Oswego | Oregon | 97035 | — |
| Not listed | Duncansville | Pennsylvania | 16635 | — |
| Not listed | Philadelphia | Pennsylvania | 19152 | — |
| Not listed | Wexford | Pennsylvania | 15090 | — |
| Not listed | Wyomissing | Pennsylvania | 19610 | — |
| Not listed | Charleston | South Carolina | 29407 | — |
| Not listed | Orangeburg | South Carolina | 29118 | — |
| Not listed | Dallas | Texas | 75246 | — |
| Not listed | Mesquite | Texas | 75150 | — |
| Not listed | Tacoma | Washington | 98405 | — |
| Not listed | Clarksburg | West Virginia | 26301 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01163747, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 7, 2012 · Synced Nov 4, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT01163747 live on ClinicalTrials.gov.